Aurora Medical GroupAurora Baycare Medical Center 2845 Greenbrier Rd, Green Bay, WI 54311 (920)2888000 (phone), (920)2885510 (fax)
Bay Care Clinic Physical Medicine 2845 Greenbrier Rd STE 340, Green Bay, WI 54311 (920)2888377 (phone), (920)2888385 (fax)
Education:
Medical School The Fourth Military Med Univ, Xian City, Shaanxi, China Graduated: 1984
Procedures:
Physical Medicine and Rehabilitation, Tests and Measurements Physical Therapy Physical Therapy Evaluation Arthrocentesis Neurological Testing
Conditions:
Cholelethiasis or Cholecystitis Gastrointestinal Hemorrhage Inguinal Hernia Malignant Neoplasm of Esophagus Varicose Veins
Languages:
Chinese English French Spanish
Description:
Dr. Chen graduated from the The Fourth Military Med Univ, Xian City, Shaanxi, China in 1984. He works in Green Bay, WI and 1 other location and specializes in Physical Medicine & Rehabilitation. Dr. Chen is affiliated with Aurora Baycare Medical Center.
Dr. Chen graduated from the Peking Union Med Coll, Beijing, Beijing, China in 1993. She works in Rego Park, NY and specializes in Pediatrics. Dr. Chen is affiliated with Flushing Hospital Medical Center and Jamaica Hospital Medical Center.
David M. Walba - Boulder CO Daniel J. Dyer - Pasadena CA Uwe Muller - Berlin, DE Peter Cobben - Waalre, NL Xin Hua Chen - Boulder CO William Thurmes - Longmont CO Michael Wand - Boulder CO
This invention provides LC compositions useful as birefringent materials in electrooptic devices which exhibit zero or low negatively sloped birefringence dispersioon (e. g. , exhibiting positive birefringence dispersion significantly lower than that of currently available LC compositions) or more preferably positively sloped birefringence dispersion in which birefringence of the material increases with wavelength. The invention provides compounds useful as components of LC compositions which exhibit negative birefringence where n is higher than n. The compounds of this invention are dimers of LC-like compounds in which the monomers are linked to each other through a high birefringence moiety (dimerization linker). The LC monomers consist of an LC core and one or two tail groups. Preferred monomers for this invention have low birefringence in comparison to the birefringence of the monomer linking moiety.
High Polarization Dopants For Ferroelectric Liquid Crystal Compositions
The invention relates to chiral nonracemic liquid crystal compounds which are useful as components in liquid crystal compositions to impart high polarization to the mixture. The materials of this invention can be combined with liquid crystal host materials to impart improved properties to mixtures. Chiral nonracemic compounds of this invention can function as additives or dopants in host materials to impart chirality into an LC material. Most generally the invention provides mixtures containing one or more chiral nonracemic dopants which have a chiral nonracemic tail that is an optionally substituted α-ester γ-lactone of the formula: where * indicates a chiral carbon; Ris a straight-chain or branched alkyl or alkenyl group wherein one or more non-neighboring carbon atoms can be replaced with an oxygen atom and wherein one or more carbons can be substituted with one or more halogens; Rand R, independently of one another, can be hydrogen, a halogen or a lower alkyl or alkenyl group; and X is hydrogen or a lower alkyl group. LC compounds having a chiral nonracemic tail of this general formula have large dipoles (and large spontaneous polarization (P)) and when doped into hosts such as achiral smectic C FLC hosts, lead to improved switching speeds of the FLC materials.
Zuchun Zhao - Pleasanton CA, US Xin Chen - San Ramon CA, US Jianchao Wang - Castro Valley CA, US Hongbin Sun - Hayward CA, US Jack Shih-Chieh Liang - Mountain View CA, US
Assignee:
Metabolex, Inc. - Hayward CA
International Classification:
A61K 31/4192 C07D 249/18 C07D 249/20
US Classification:
514359, 548257, 548260
Abstract:
Substituted phenylacetic acids, phenylethanols and related compounds are provided that are useful in treating or controlling a number of diseases associated with glucose metabolism, lipid metabolism and insulin secretion.
The invention provides LC compositions that exhibit V-shaped switching when aligned in an analog device configuration and exhibit bistability when aligned in a bookshelf-type device configuration. The invention more specifically provides LC compositions of formula 1 and particularly chiral nonracemic compounds of formula 1 which exhibit bistable switching as well as V-shaped switching when aligned in appropriate device configurations. The invention also provides methods of using the compounds of the invention in making LC compositions and electooptical devices comprising an aligned layer of the compositions of this invention.
High Polarization Ferroelectric Liquid Crystal Compositions
The invention relates to chiral nonracemic liquid crystal compounds having achiral tails comprising a perfluoroalkyl terminal portion which are useful as components in liquid crystal to impart high polarization to the mixture. The materials of this invention can be combined with known liquid crystal host materials to impart improved properties. Chiral nonracemic compounds of this invention can function as additives or dopants in host materials to impart chirality into an LC material.
Α-(Trifluoromethyl-Substituted Aryloxy, Arylamino, Arylthio Or Arylmethyl)-Trifluoromethyl-Substituted Phenylacetic Acids And Derivatives As Antidiabetic Agents
Zuchun Zhao - Pleasanton CA, US Xin Chen - San Ramon CA, US Jianchao Wang - Castro Valley CA, US Hongbin Sun - Hayward CA, US Jack Shih-Chieh Liang - Mountain View CA, US
Assignee:
Metabolex, Inc. - Hayward CA
International Classification:
C07C 69/73 C07C 315/00 A01N 29/02
US Classification:
560 61, 514746, 514757, 562430, 560 60
Abstract:
Compounds having a formula:.
Resolution Of Α-(Phenoxy) Phenylacetic Acid Derivatives With Naphthyl-Alkylamines
Peng Cheng - Union City CA, US Jingyuan Ma - Sunnyvale CA, US Xin Chen - San Ramon CA, US Yan Zhu - Foster City CA, US Zuchun Zhao - Pleasanton CA, US
Assignee:
Metabolex, Inc. - Hayward CA
International Classification:
C07C 59/56
US Classification:
562472, 562401, 562405, 560 62
Abstract:
The present invention provides a methods and compounds for producing an enantiomerically enriched α-(phenoxy)phenylacetic acid compound of the formula:.
Xin Chen - San Ramon CA, US Peng Cheng - Union City CA, US L. Edward Clemens - Davis CA, US Jeffrey D. Johnson - Moraga CA, US Jingyuan Ma - Sunnyvale CA, US Alison Murphy - Milpitas CA, US Imad Nashashibi - San Jose CA, US Christoper J. Rabbat - San Jose CA, US Jiangao Song - Sunnyvale CA, US Maria E. Wilson - San Francisco CA, US Yan Zhu - Foster City CA, US Zuchun Zhao - Pleasanton CA, US
Assignee:
Metabolex Inc. - Hayward CA
International Classification:
A61K 31/425
US Classification:
514365, 544331, 546209, 548203, 548252
Abstract:
Compounds, compositions, and methods relating to 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine or a pharmaceutically acceptable salt thereof are provided for the treatment of Type II diabetes and other diseases associated with poor glycemic control.
Mar 2013 to 2000 Sr Compliance Officer - Fair LendingCiti Bank Long Island City, NY Nov 2011 to Mar 2013 Risk Analyst, VP - Credit Risk PolicyJPMorgan Chase & Co Iselin, NJ Oct 2010 to Nov 2011 Compliance Officer - Fair LendingOperational Risk Management
Oct 2008 to Oct 2010 Risk AnalystORM & COR initiatives Phoenix, AZ Oct 2008 to Oct 2008 Management Associate - Leadership Development Program
Education:
Rutgers University New Brunswick, NJ Jan 2006 to May 2007 Bachelor of Arts in EconomicsBergen Community College Paramus, NJ Sep 2004 to Dec 2005 Associate in ScienceMinjiang University Fuzhou, CN Sep 2001 to May 2004 Diploma in Computer Science
Dec 2011 to Present Imaging ScientistMass General Hospital
Oct 2010 to Present Instructor(Research Faculty)Mass General Hospital Boston, MA Oct 2010 to Sep 2011 Assistant Computer ScientistFairchild Imaging Milpitas, CA Jul 2009 to May 2010 Imaging EngineerUniversity of California at San Francisco San Francisco, CA Mar 2008 to Aug 2009 PostDoc Research AssociateNVIDIA Santa Clara, CA Nov 2007 to Feb 2008 Intern, Applied EngineerResearch Assistantship, Biomedical Imaging Lab, University of Hawaii at Manoa
Aug 2003 to Dec 2007Research Assistantship, Intelligent Control Lab, Hefei University of Technology
Aug 2000 to Dec 2003
Education:
University of Hawaii Dec 2007 Ph. D. in Image Processing and Computer VisionHefei University of Technology Jul 2003 M.S. in Pattern Recognition and Intelligence Control
Jan 2012 to Present Director of AccountingSource Photonics, Inc Chatsworth, CA Mar 2010 to Dec 2011 Director of Technical AccountingVolt Information Sciences Inc Orange, CA Apr 2009 to Mar 2010 Internal Audit ManagerErnst & Young LLP San Jose, CA Jul 2004 to Apr 2009 Audit Manager, Advisory & Assurance Business ServicesM. Green and Company LLP Visalia, CA Sep 2002 to May 2004 CPAJapan Tobacco HK, HK Sep 1997 to Aug 2000 Assistant Manager
Education:
California State University Dec 2002 Master of Business Administration in FinanceHubei University Jun 1993 Bachelor of Arts in English
2011 to 2000Connective Tissue Oncology Society (CTOS)
2011 to 2000Postdoctoral
2000 to 2000 Research AssociatePostdoctoral
2001 to Jan 2010Postdoctoral San Diego, CA 2010 to 2010Postdoctoral
2008 to 2008Postdoctoral
2006 to 2006Dennis JE Philadelphia, PA 2006 to 2006Postdoctoral
2005 to 2005Postdoctoral
2005 to 2005Washington Convention Washington, DC 2005 to 2005Washington Convention Washington, DC 2005 to 2005 DC, USA. Selected as a New Investigator Recognition Awards (NIRA) finalistPostdoctoral Bethesda, MD 2004 to 2004 New Investigator Recognition AwardsPostdoctoral
2004 to 2004Treatment of Osteoporosis Bethesda, MD 2004 to 2004EM. Lipopolysaccharide
2004 to 2004 Bone Miner ResPostdoctoral Minneapolis, MN 2003 to 2003USA. J Minneapolis, MN 2003 to 2003 Bone Miner Res13. Chen X, Dai JC, Orellana SA, and Greenfield
2003 to 2003 Miner ResASBMR San Antonio, TX 2002 to 2002 USA. J Bone Miner ResPTH and TNFalpha
2002 to 2002 Texas, USA. J Bone Miner ResASBMR Phoenix, AZ 2001 to 2001 USA. J Bone Miner ResDepartment of Biosignal Pathophysiology
1994 to 2000 Visiting Scientist and Graduate StudentKagojima, Japan Yokohama, JP 1997 to 1997Health Association
1996 to 1996Japan University Health Association, Nagano, Japan
1994 to 1994Department of Pathophysiology
1986 to 1993 Teaching Assistant and LecturerDepartment of Pathophysiology
1986 to 1993 Graduate Student and Research AssistantDepartment of Pathophysiology
1991 to 1991Department of Pathophysiology
1990 to 1990
Education:
Case Western Reserve University 2003 to 2000 Research AssociateSchool of Medicine 2000 to 2003Kobe University School of Medicine 1994 to 2000 Ph.D. in biosignal PathophysiologyChina Medical University and Bethune Medical University 1993 to 1994 English and Japanese TraineeHunan Medical University and Hengyang Medical College 1986 to 1989 Master's in PathophysiologyNorth China Coal Medical College 1981 to 1986 Doctor in MedicalSchool of Medicine, Case Western Reserve University
The next step is to investigate whether it is possible to develop a drug delivery system based on graphene oxide for Alzheimers disease, says Xin Chen. We also want to test whether graphene oxide has beneficial effects in additional models of neurodegenerative diseases, such as Parkinsons diseaReference: Graphene Oxide Attenuates Toxicity of Amyloid- Aggregates in Yeast by Promoting Disassembly and Boosting Cellular Stress Response by Xin Chen, Santosh Pandit, Lei Shi, Vaishnavi Ravikumar, Julie Bonne Khler, Ema Svetlicic, Zhejian Cao, Abhroop Garg, Dina Petranovic and Ivan Mijakovic,
Date: Oct 04, 2023
Category: Health
Source: Google
Cells Get a Makeover, Cancer Follows: A Path to New Therapies or Warning to ...
In this case, two young scientists, Holger Willenbring and Xin Chen, were trying to study a deadly, and fairly common, form of liver cancer called hepatocellular carcinoma. Chen and her group hoped to induce the cancer by activating oncogenes, genes that trigger cancer, in a group of liver cells cal
Although the components have each been reported before, "It is probably one of the first and best demonstrations of a combination of nanotechology, hydrogen-fuel technology and soft robotics," said Xin Chen of Boston University who was not a part of the study.
Columbia University - Computer Science, Zhejiang University - Information Science and Engineering
Xin Chen
Work:
Terminator skynet - Eliminator (2090-3015) Skynet
Education:
Sint-montfortcollege
Tagline:
I'm the chinese eliminator
Xin Chen
Work:
TrendSource - Marketing Associate (2011)
Education:
San Diego State University - Marketing, Grossmont College - Business Administration
Tagline:
Dream Flighter!
Xin Chen
Education:
Duke University - Master of Economics, Miami University - Business Economics
About:
Disciple of Love and Beauty.Defender of Rationality and Humanity.
Xin Chen
Work:
COMODO - QA Engineer (2009)
Education:
Beijing Jiaotong University - Electromagnetic Compatibility, Beijing Jiaotong University - Optics
Xin Chen
Education:
Pennsylvania State University - CSE, Nanjing University - CS, None
Xin Chen
Education:
Purdue University
About:
I am currently a PhD student in the School of Engineering Education at Purdue University. I have a BS in Electrical Engineering. My research focuses on Social Media Analytics in the context of enginee...
Bragging Rights:
I like cooking and beautiful food; I think friends are very important in life.